In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Cardiac magnetic resonance with 4D Flow Imaging for mitral regurgitation severity assessment

Session Poster session 1

Speaker Marco Guglielmo

Congress : EuroCMR 2019

  • Topic : imaging
  • Sub-topic : Cardiac Magnetic Resonance: Flow Imaging
  • Session type : Poster Session
  • FP Number : P163

Authors : M Guglielmo (Milan,IT), G Muscogiuri (Milan,IT), A Baggiano (Milan,IT), A Guaricci (Bari,IT), D Andreini (Milan,IT), S Mushtaq (Milan,IT), E Conte (Milan,IT), G Bonalumi (Milan,IT), M Zanobini (Milan,IT), F Alamanni (Milan,IT), M Pepi (Milan,IT), G Pontone (Milan,IT)

Authors:
M Guglielmo1 , G Muscogiuri1 , A Baggiano1 , A Guaricci2 , D Andreini1 , S Mushtaq1 , E Conte1 , G Bonalumi1 , M Zanobini1 , F Alamanni1 , M Pepi1 , G Pontone1 , 1Monzino Cardiology Center, IRCCS, Milan, Italy - Milan - Italy , 2University of Bari - Bari - Italy ,

Citation:
European Heart Journal - Cardiovascular Imaging ( 2019 ) 20 ( Supplement 2 ), ii120

BACKGROUND: Cardiac Magnetic Resonance (CMR) has recently emerged as a technique more accurate than echocardiography in assessing the severity of mitral regurgitation (MR). Standard method for mitral regurgitation  determination with CMR is measuring the regurgitant volume (RV) as the difference between the LV stroke volume obtained with SSFP (Steady state free precession) cine imaging and the forward flow obtained with phase contrast (PC) imaging. It has already been demostrated that there is a strong correlation between post-surgical left ventricle (LV) remodeling and MR severity as assessed by CMR SSFP - PC imaging.

However, CMR SSFP - PC imaging examination is time consuming, requiring up to one hour of overall scan time. More recently, time-resolved phase contrast CMR with velocity encoding along all three flow directions and three-dimensional (3D) anatomic coverage (also termed ‘4D flow’) has been developed. CMR 4D flow imaging has the potential for a comprehensive morphofunctional cardiac evaluation reducing the overall scan time to 15 minutes even without contrast agents administration.

The purpose of this study was to compare CMR 4D flow and SSFP imaging for the assessment of MR severity using the degree of left ventricular (LV) remodeling after surgery as the reference standard.

METHODS: 10 consecutive patients (age: 59 ± 10) with indication to mitral valve plasty for severe mitral regurgitation were enrolled. MR severity was assessed using both CMR SSFP - PC imaging and CMR 4D flow imaging without the use of contrast agents. The pre-surgical estimate of regurgitant severity was correlated with the postoperative decrease in LV end-diastolic volume.

RESULTS: Agreement between CMR SSFP-PC imaging and CMR 4D flow imaging for MR regurgitant volume (RV) was excellent for both pre (r = 0.8, p<0.05, mean difference 5.1 mL) and post surgery  (r= 0.9, p<0.05) evaluations. There was a strong correlation between post-surgical LV remodeling and MR severity as assessed by CMR 4D flow imaging (r=0.81, p <0.005) that was comparable to CMR SSFP-PC (r=0.78, p<0.005). The average time for MR assessment with CMR SSFP and PC imaging evaluation was 10 minutes, 2 minutes with CMR 4D flow imaging.

CONCLUSIONS: CMR 4D flow imaging without contrast agents allows an accurate and quick evaluation of MR regurgitant volume. There is a strong correlation between MR severity assessed with CMR 4D flow imaging and post-surgical LV remodeling. Indeed, CMR 4D flow imaging may represent an alternative method for MR severity assessment.



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are